Can We Provide Safe Training and Competition for All Athletes? From Mobile Heart Monitoring to Side Effects of Performance-Enhancing Drugs and MicroRNA Research
Funding
Conflicts of Interest
References
- Stępień-Wojno, M.; Ponińska, J.; Biernacka, E.K.; Foss-Nieradko, B.; Chwyczko, T.; Syska, P.; Płoski, R.; Bilińska, Z.T. A Recurrent Exertional Syncope and Sudden Cardiac Arrest in a Young Athlete with Known Pathogenic p.Arg420Gln Variant in the RYR2 Gene. Diagnostics 2020, 10, 435. [Google Scholar] [CrossRef]
- Ostby, S.A.; Bos, J.M.; Owen, H.J.; Wackel, P.L.; Cannon, B.C.; Ackerman, M.J. Competitive Sports Participation in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia: A Single Center’s Early Experience. JACC Clin. Electrophysiol. 2016, 2, 253–262. [Google Scholar] [CrossRef]
- Książczyk, T.M.; Pietrzak, R.; Werner, B. Management of Young Athletes with Asymptomatic Preexcitation-A Review of the Literature. Diagnostics 2020, 10, 824. [Google Scholar] [CrossRef]
- Pellicia, A.; Caselli, S. Structural and functional adaptations in the athlete’s heart. In The ESC Textbook of Sports Cardiology, 1st ed.; Pellicia, A., Heidbuchel, H., Corrado, D., Börjesson, M., Sharma, S., Eds.; Oxford University Press: Oxford, UK, 2019. [Google Scholar]
- Król, W.; Price, S.; Śliż, D.; Parol, D.; Konopka, M.; Mamcarz, A.; Wełnicki, M.; Braksator, W. A Vegan Athlete’s Heart-Is It Different? Morphology and Function in Echocardiography. Diagnostics 2020, 10, 477. [Google Scholar] [CrossRef]
- Gajda, R.; Klisiewicz, A.; Matsibora, V.; Piotrowska-Kownacka, D.; Biernacka, E.K. Heart of the World’s Top Ultramarathon Runner-Not Necessarily Much Different from Normal. Diagnostics 2020, 10, 73. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gajda, R. Is Continuous ECG Recording on Heart Rate Monitors the Most Expected Function by Endurance Athletes, Coaches, and Doctors? Diagnostics 2020, 10, 867. [Google Scholar] [CrossRef] [PubMed]
- Gajda, R. Heart Rate Monitor Instead of Ablation? Atrioventricular Nodal Re-Entrant Tachycardia in a Leisure-Time Triathlete: 6-Year Follow-Up. Diagnostics 2020, 10, 391. [Google Scholar] [CrossRef] [PubMed]
- Grzebisz, N. Determinants of the Cardiovascular Capacity of Amateur Long-Distance Skiers during the Transition Period. Diagnostics 2020, 10, 675. [Google Scholar] [CrossRef] [PubMed]
- Hoffmann, B.; Flatt, A.A.; Silva, L.E.V.; Młyńczak, M.; Baranowski, R.; Dziedzic, E.; Werner, B.; Gąsior, J.S. A Pilot Study of the Reliability and Agreement of Heart Rate, Respiratory Rate and Short-Term Heart Rate Variability in Elite Modern Pentathlon Athletes. Diagnostics 2020, 10, 833. [Google Scholar] [CrossRef] [PubMed]
- Gąsior, J.S.; Hoffmann, B.; Silva, L.E.V.; Małek, Ł.; Flatt, A.A.; Baranowski, R.; Werner, B. Changes in Short-Term and Ultra-Short Term Heart Rate, Respiratory Rate, and Time-Domain Heart Rate Variability Parameters during Sympathetic Nervous System Activity Stimulation in Elite Modern Pentathlonists-A Pilot Study. Diagnostics 2020, 10, 1104. [Google Scholar] [CrossRef] [PubMed]
- Merghani, A.; Malhotra, A.; Sharma, S. The U-shaped relationship between exercise and cardiac morbidity. Trends Cardiovasc. Med. 2016, 26, 232–240. [Google Scholar] [CrossRef] [PubMed]
- Małek, Ł.A.; Czajkowska, A.; Mróz, A.; Witek, K.; Nowicki, D.; Postuła, M. Factors Related to Cardiac Troponin T Increase after Participation in a 100 Km Ultra-Marathon. Diagnostics 2020, 10, 167. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sivalokanathan, S.; Małek, Ł.A.; Malhotra, A. The Cardiac Effects of Performance-Enhancing Medications: Caffeine vs. Anabolic Steroids. Diagnostics 2021, 11, 324. [Google Scholar] [CrossRef] [PubMed]
- Soplinska, A.; Zareba, L.; Wicik, Z.; Eyileten, C.; Jakubik, D.; Siller-Matula, J.M.; De Rosa, S.; Malek, L.A.; Postula, M. MicroRNAs as Biomarkers of Systemic Changes in Response to Endurance Exercise-A Comprehensive Review. Diagnostics 2020, 10, 813. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Małek, Ł.A.; Postuła, M. Can We Provide Safe Training and Competition for All Athletes? From Mobile Heart Monitoring to Side Effects of Performance-Enhancing Drugs and MicroRNA Research. Diagnostics 2021, 11, 492. https://doi.org/10.3390/diagnostics11030492
Małek ŁA, Postuła M. Can We Provide Safe Training and Competition for All Athletes? From Mobile Heart Monitoring to Side Effects of Performance-Enhancing Drugs and MicroRNA Research. Diagnostics. 2021; 11(3):492. https://doi.org/10.3390/diagnostics11030492
Chicago/Turabian StyleMałek, Łukasz A., and Marek Postuła. 2021. "Can We Provide Safe Training and Competition for All Athletes? From Mobile Heart Monitoring to Side Effects of Performance-Enhancing Drugs and MicroRNA Research" Diagnostics 11, no. 3: 492. https://doi.org/10.3390/diagnostics11030492
APA StyleMałek, Ł. A., & Postuła, M. (2021). Can We Provide Safe Training and Competition for All Athletes? From Mobile Heart Monitoring to Side Effects of Performance-Enhancing Drugs and MicroRNA Research. Diagnostics, 11(3), 492. https://doi.org/10.3390/diagnostics11030492